Dual-Energy CT muscle fat fraction as a new imaging biomarker of body composition and survival predictor in critically ill patients - Top-Institutions - MDSpire

Dual-Energy CT muscle fat fraction as a new imaging biomarker of body composition and survival predictor in critically ill patients

  • By

  • Jennifer Erley

  • Kevin Roedl

  • Ann-Kathrin Ozga

  • Geraldine de Heer

  • Niklas Schubert

  • Julia Breckow

  • Christoph Burdelski

  • Enver Tahir

  • Stefan Kluge

  • Tobias B. Huber

  • Jin Yamamura

  • Gerhard Adam

  • Isabel Molwitz

  • May 22, 2024

  • 0 min

Share

Top Institutions in Radiology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Critical Care Medicine
    • Radiology
    • Muscle Imaging
    • Body Composition Research

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Critical Care Medicine
    • Radiology
    • Muscle Biology
    • Imaging Biomarkers

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Radiology
    • Critical Care Medicine
    • Muscle Imaging
    • Body Composition Analysis

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Critical Care Medicine
    • Radiology
    • Muscle Metabolism
    • Imaging Biomarkers

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Critical Care Medicine
    • Radiology
    • Body Composition Imaging
    • Muscle Quality Assessment

Original Source(s)

Dual-Energy CT muscle fat fraction as a new imaging biomarker of body composition and survival predictor in critically ill patients

  • by Jennifer Erley, Kevin Roedl, Ann-Kathrin Ozga, Geraldine de Heer, Niklas Schubert, Julia Breckow, Christoph Burdelski, Enver Tahir, Stefan Kluge, Tobias B. Huber, Jin Yamamura, Gerhard Adam, Isabel Molwitz

  • May 22, 2024

Related Content

FDA Cleared ≠ FDA Validated

Most AI medical devices reach the market without independent evidence of safety or effectiveness.

Assessment of bone density and microarchitecture in patients with familial partial lipodystrophy

Beyond the radiology report: a multi-criteria decision analysis to define essential CT parameters for abdominal wall reconstruction